Nipro Corp NPRRF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $9.96
- Day Range
- $9.24–9.40
- 52-Week Range
- $8.23–9.96
- Bid/Ask
- $6.11 / $15.54
- Shares Outstanding
- 163.10M
- Market Cap
- $1.53B
- Volume/Avg
- 2,108 / 1,308
Key Statistics
- Price/Earnings (Normalized)
- 30.02
- Price/Sales
- 0.40
- Dividend Yield (Trailing)
- 2.07%
- Dividend Yield (Forward)
- 2.07%
- Dividend Payment Schedule
- Jun, Dec
- Total Yield
- 2.08%
Company Profile
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm is divided into three segment: Medical segment sells medical devices related to injections and infusions, artificial organs, high-performance devices, and dialysis, as well as pharmaceuticals related to diabetes, generics, and kit formulations in Japan and overseas; Pharmaceutical segment handles the consignment sales of pharmaceuticals from pharmaceutical companies, including containers for kit formulations; and Pharmaceutical Packaging handles glass for medical use in Japan, including glass for vials and ampoules, and glassware. Nipro generates the majority of its revenue in Japan, while it also has its presence in America, Europe and Asia.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Core
- Total Number of Employees
- 39,763
- Website
- http://www.nipro.co.jp
Valuation
|
Metric
|
NPRRF
|
|---|---|
Price/Earnings (Normalized) | 30.02 |
Price/Book Value | 0.88 |
Price/Sales | 0.40 |
Price/Cash Flow | 3.14 |
Price/Earnings
NPRRF
Financial Strength
|
Metric
|
NPRRF
|
|---|---|
Quick Ratio | 0.63 |
Current Ratio | 1.38 |
Interest Coverage | 3.50 |
Quick Ratio
NPRRF
Profitability
|
Metric
|
NPRRF
|
|---|---|
Return on Assets (Normalized) | 1.92% |
Return on Equity (Normalized) | 8.84% |
Return on Invested Capital (Normalized) | 3.00% |
Return on Assets
NPRRF
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|m!fB$x@ | LOCK|Y@< | $150B | |||
| Becton Dickinson & Co
BDX
| LOCK|Rh | LOCK|n#?M | $50B | |||
| ResMed Inc
RMD
| LOCK|@##&bcNY | LOCK|G@^x$ | $32B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|&BTVJdp | LOCK|NSC@M | $32B | |||
| Alcon Inc
ALC
| LOCK|dDhrLr# | LOCK|k!B%@ | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|xCLJg@j | LOCK|bK | $26B | |||
| Solventum Corp
SOLV
| LOCK|<<Kn!n | LOCK|K#x | $15B | |||
| Baxter International Inc
BAX
| LOCK|VG | LOCK|<!#$ | $13B | |||
| Repligen Corp
RGEN
| LOCK|Rf$<^$n | LOCK|?@fJf | $11B | |||
| The Cooper Companies Inc
COO
| LOCK|wRTDw?$ | LOCK|VW>YJ | $10B |
United States